MK0462

· Organon and Co

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MK0462, covering 2010-07-23 to 2011-05-04. Get the full timeline:

Most recent: Clinical Trial Update: MK0462 in Treatment of Migraine With Recurrence (MK0462-022) [Phase 3]